Hannah Björn Andtback

Articles

Article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2022;10(1):e003198
Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma.
Spassova I; Ugurel S; Kubat L; Zimmer L; Terheyden P; Mohr A; Björn Andtback H; Villabona L; Leiter U; Eigentler T; Loquai C; Hassel JC; Gambichler T; Haferkamp S; Mohr P; Pfoehler C; Heinzerling L; Gutzmer R; Utikal JS; Horny K; Schildhaus H-U; Habermann D; Hoffmann D; Schadendorf D; Becker JC
Article: CANCERS. 2021;13(2):E265-265
Sex Differences in Overall Survival and the Effect of Radiotherapy in Merkel Cell Carcinoma-A Retrospective Analysis of A Swedish Cohort
Andtback HB; Bjornhagen-Safwenberg V; Shi H; Lui W-O; Masucci GV; Villabona L